Abstract
The biotransformations of artemisinin and artemisinin derivatives leading to metabolites that may serve as prospective candidates for antimalarial evaluation or as starting materials for hemisynthesis of antimalarial derivatives are reviewed, focusing on the preparation of regio- and stereoselectively hydroxylated derivatives still possessing the 1,2,4- trioxane structure that can be used as scaffolds for the production of novel antimalarials with increased water solubility, lower toxicity and decreased potential for resistance. A special emphasis has been also placed on the recent manufacturing of artemisinin and derivatives via microbiological methods, involving cloning and overexpression of biosynthetic enzymes and allowing to design an alternative route for artemisinin production.
Keywords: Arteether, artemether, artesunate, artemisia annua, bacteria, fungi, hydroxylations, synthetic reactions, molecular diversity, microbial generation.
Current Bioactive Compounds
Title:Microbial Transformations of Artemisinin and Artemisinin Derivatives: an Example of the Microbial Generation of Molecular Diversity
Volume: 8 Issue: 2
Author(s): Robert Azerad
Affiliation:
Keywords: Arteether, artemether, artesunate, artemisia annua, bacteria, fungi, hydroxylations, synthetic reactions, molecular diversity, microbial generation.
Abstract: The biotransformations of artemisinin and artemisinin derivatives leading to metabolites that may serve as prospective candidates for antimalarial evaluation or as starting materials for hemisynthesis of antimalarial derivatives are reviewed, focusing on the preparation of regio- and stereoselectively hydroxylated derivatives still possessing the 1,2,4- trioxane structure that can be used as scaffolds for the production of novel antimalarials with increased water solubility, lower toxicity and decreased potential for resistance. A special emphasis has been also placed on the recent manufacturing of artemisinin and derivatives via microbiological methods, involving cloning and overexpression of biosynthetic enzymes and allowing to design an alternative route for artemisinin production.
Export Options
About this article
Cite this article as:
Azerad Robert, Microbial Transformations of Artemisinin and Artemisinin Derivatives: an Example of the Microbial Generation of Molecular Diversity, Current Bioactive Compounds 2012; 8 (2) . https://dx.doi.org/10.2174/157340712801784750
DOI https://dx.doi.org/10.2174/157340712801784750 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mechanisms of T Cell Tolerance and Suppression in Cancer Mediated by Tumor-Associated Antigens and Hormones
Current Cancer Drug Targets A New Approach for Cancer Immunotherapy Based on the Cancer Stem Cell Antigens Properties
Current Molecular Medicine Tumor-Receptor Imaging in Breast Cancer: A Tool for Patient Selection and Response Monitoring
Current Molecular Medicine Targeting Neurotrophic Signal Transduction Pathways in the Treatment of Mood Disorders
Current Signal Transduction Therapy Use of Mouse Models to Evaluate Roles of Nuclear Receptors and their Ligands in the Pathogenesis and Treatment of Atherosclerosis
Current Drug Targets An Emerging Molecular Target in Melanoma: Cellular Carbonyl Stress and the Inhibition of Mitochondrial Survival Pathways by Carbonyl Scavenger Agents
Current Cancer Therapy Reviews Mitocans: Mitochondrial Targeted Anti-Cancer Drugs as Improved Therapies and Related Patent Documents
Recent Patents on Anti-Cancer Drug Discovery Smart Synthetic Polymer Nanocarriers for Controlled and Site-Specific Drug Delivery
Current Topics in Medicinal Chemistry A Concise Update on the Relevance of Secretory Phospholipase A2 Group IIA and its Inhibitors with Cancer
Medicinal Chemistry Medicinal Chemistry and the Molecular Operating Environment (MOE): Application of QSAR and Molecular Docking to Drug Discovery
Current Topics in Medicinal Chemistry RING-, HECT-, and RBR-type E3 Ubiquitin Ligases: Involvement in Human Cancer
Current Cancer Drug Targets Shooting At the DARC: Potential Issues with Species-Specific Antimalarials
Infectious Disorders - Drug Targets Fisetin Attenuates AKT Associated Growth Promoting Events in AflatoxinB1 Induced Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Preface
Recent Patents on Anti-Cancer Drug Discovery Interplay between Epigenetics & Cancer Metabolism
Current Pharmaceutical Design Stable Synthetic Bacteriochlorins: Potent Light-Activated Anti-Cancer Drugs
Current Organic Chemistry LW-AFC, A New Formula Derived from Liuwei Dihuang Decoction, Ameliorates Cognitive Deterioration and Modulates Neuroendocrine-Immune System in SAMP8 Mouse
Current Alzheimer Research Therapeutic Angiogenesis in Ischemic Tissues by Growth Factors and Bone Marrow Mononuclear Cells Administration: Biological Foundation and Clinical Prospects
Current Stem Cell Research & Therapy Patent Selections
Recent Patents on DNA & Gene Sequences Mitochondrial Dysfunction and Targeted Drugs: A Focus on Diabetes
Current Pharmaceutical Design